Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Johnson Controls International PLC (JCI) vs Tempus AI (TEM) Price & Performance

Johnson Controls International PLCTrade

Price performance (Past 24H)

Key statistics

Johnson Controls International PLC vs Tempus AI — how do they compare? Johnson Controls International PLC trades at $155.47 (market cap $91.29B), while Tempus AI trades at $55.47 (market cap $9.93B). The key difference: Johnson Controls International PLC is far larger — about 9.2× Tempus AI's market cap, and Johnson Controls International PLC pays a 1.06% dividend while Tempus AI pays none. Which is the better fit depends on your goals.

JCITEM
Market Cap
$91.29B$9.93B
Sector
IndustrialsBroad Market / Factor
52-Week High
$154.76$103.25
52-Week Low
$103.52$41.55
Enterprise Value
$100.12B$10.56B
Dividend Yield
1.06%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Johnson Controls International PLC

Johnson Controls International (JCI) trades at $152.21, down 1.51% on the day, but maintains a bullish technical outlook with strong analyst support. The company reported robust Q2 2026 earnings, beating estimates with EPS of $1.42 versus $1.30 expected, and raised full-year guidance. Fundamentals show solid revenue growth and expanding net income margins, though valuation multiples like a P/E of 42.88 appear elevated. Recent news highlights strong demand for its thermal management systems, particularly in data centers.

JCI's outlook is positive, driven by operational strength and strategic positioning in high-growth markets like AI infrastructure. Investment opportunities include continued earnings beats and market share gains in energy efficiency solutions. Key risks involve high valuation sensitivity, competitive pressures, and macroeconomic factors affecting construction and industrial spending. The consensus price target of $168.25 suggests ~10% upside from current levels.

Tempus AI

Tempus AI (TEM) trades at $52.05, up 12.86% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat revenue estimates and raised 2026 sales guidance. The stock is technically bullish with moving averages supporting upside, while fundamentals show revenue growth to $1.4 billion in 2026 but persistent net losses. Recent news highlights expansion through the Personalis acquisition and AI-driven precision medicine advancements.

Outlook: Growth prospects are robust with AI adoption in healthcare and strategic deals, but high valuation ratios and negative profitability pose risks. Analysts are bullish with a $61.57 consensus target, though cash burn and competitive pressures require monitoring for sustained investor confidence.

Returns comparison

Trailing returns across standard periods

About Johnson Controls International PLC

Johnson Controls manufactures, installs, and services HVAC systems, building management systems and controls, industrial refrigeration systems, and fire and security solutions. Commercial HVAC accounts for about 40% of sales, fire and security also represents 40% of sales, and residential HVAC, industrial refrigeration, and other solutions account for the remaining 20% of revenue. In fiscal 2021, Johnson Controls generated over $23.5 billion in revenue.

Read more on JCI

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM